TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
SKYE

Skye Bioscience, Inc.

Healthcare · Biotechnology

1.70$ -1.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow SKYE
Line item 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
0.45 -3.39 -334.26 -436.99 -356.83 -218.48 -59.99 -90.64 -52.32 -31.85 -0.03 -15.93 -5.53 -8.69
– 2.54 0.36 1.17 1.50 0.53 0.02 0.02 0.02 0.17 0.00 0.14 0.07 0.15
– – 2.05 48.57 70.94 40.32 10.27 10.23 2.62 4.28 0.00 1.13 1.82 1.57
– – – – -43.21 5.22 229.61 -120.39 -1.15 3.80 – – – –
-0.60 28.16 95.24 -49.06 4.07 -21.45 1.52 4.45 0.81 3.18 0.00 -0.54 -0.58 0.95
0.00 11.49 4.43 0.23 1.12 1.30 0.07 0.11 0.06 0.45 0.00 0.01 0.35 0.00
– -8.91 -4.43 -0.23 -1.12 -1.30 -0.07 -0.11 -0.06 -0.45 0.01 7.53 -0.05 -3.93
– – – – 50.22 33.12 35.70 0.08 4.90 0.00 0.00 5.38 0.00 –
2.47 18.33 378.18 790.51 40.94 232.71 84.31 90.29 57.91 64.34 0.00 18.78 18.32 0.01
2.92 6.03 39.48 353.29 -317.00 12.93 24.25 -0.35 5.53 32.04 -0.02 10.38 12.73 -12.61
0.45 -14.88 -338.69 -437.23 -357.94 -219.78 -60.06 -90.64 -52.38 -32.30 -0.03 -15.95 -5.89 -8.69

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?